NCT07145671Active, not recruiting
The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions
The COCCOS Study: Implementing and Evaluating a Transition Program for Young Persons With Chronic Conditions
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting. Specific objectives for this study are: (1) examining the impact of the program in terms of patient-reported health outcomes, (2) examining patients' and healthcare providers' experiences related to the program implementation process, and (3) examining the impact of the program in terms of cost-effectiveness.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 65 (actual)
- First submitted
- 26 Jun 2025
- Start date
- 13 Mar 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Universiteit Antwerpen
- Diseases
- Obesity, Asthma, Type 1 diabetes
- NCT number
- NCT07145671
What you commit to
- Study type: Interventional
- Participants enrolled: 65
- From 13 Mar 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Applicable for both CG and IG:
- \- patients with severe mental, cognitive or neurological problems will be excluded
Who the study is looking for
- For participants in the intervention group (IG):
- 17 years old;
- diagnosed with type 1 diabetes, asthma and/or obesity;
- who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
- are Dutch speaking;
- planned to transfer to adult care within the next 12 months.
- For participants in the control group (CG):
- age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months)
- diagnosed with type 1 diabetes, asthma and/or obesity;
- who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
- are Dutch speaking;
- planned to transfer to adult care within the next 12 months.
Age in the registry: 16 years to 19 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent university hospital Coordinator of this site? Confirm its status | Ghent | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.